News

ALS-886 is a small molecule therapeutic that, in preclinical studies, has demonstrated efficacy in reducing and preventing tissue damage in the lungs. Defence Science and Technology Laboratory (Dstl)

Intertrade has placed orders for ViziLite Plus and plans to immediately begin training its sales representatives and preparing the market for the product launch. Zila’s ViziLite Plus with

Under the terms of the agreement announced earlier, Restore shareholders will receive $1.60 per share in cash for each share of Restore common stock they own. The total

This US-based, multi-center, placebo-controlled, double-blinded study will identify the maximally efficacious dose of MPI-676 to investigate in the pivotal Phase III program. The Phase IIb dose ranging trial

Prior to joining OptiMedica, Mr Murray spent more than 20 years at Guidant and its predecessor, Advanced Cardiovascular Systems. Mr Murray brings to OptiMedica more than 25 years

Affinity BioReagents provides recombinant proteins and custom antibody-production services. The company had annual revenues of approximately $6 million in 2007, and will be integrated into Thermo Fisher’s analytical

Winner Medical’s PurCotton products are said to combine the superior characteristics of both natural cotton and materials made using non-woven technology. Winner Medical’s patented manufacturing process enables the

ActiPatch is said to be a wafer thin patch with an embedded battery-operated microchip that delivers weeks of continuous pulsed RF therapy for less than a dollar a

Most recently, Ms Heller was head of strategic alliances at Novartis Institutes for Biomedical Research, the global research organization for Novartis. Previously she had served as vice president